HPV Vaccine Prevent Cervical Cancer

PREVENTION by early detection (screening) to infection Human Papilloma Virus (HPV), can be done early without having to wait until the detection of a  cancer women's killer. 

Most of the women and housewives detected cervical cancer or cervical cancer when it was advanced stage and it is very difficult to cure.

Cervical cancer journey itself is very long before a woman suffering from cervical cancer detected. It takes 10 to 20 years after HPV infection (asymptomatic) to a person known to have cervical cancer. However, not all HPV infections will develop into cancer, because most of these infections can be abated, and settled a small fraction develops (progressive) toward the cancer.

If someone is suffering from cervical cancer detected at the age of 40 years, it could be HPV infects began at the age of 20 years. 

Prior to becoming cancerous, first person experiences two phases, called low-grade lesions, that is, when abnormalities in the cervical epithelium of less than one-third of new parts, and a high degree of lesion, ie when the epithelium abnormalities already reached two-thirds, or even an entire layer epithelium. 

Intervention or prevention of the spread of cervical cancer can be done in two ways, namely primary prevention and secondary prevention. Primary prevention includes lifestyle improvement, promotion, education and vaccine. 

Primary prevention of itself can be done now, ranging from personal hygiene, with no change partners, do not smoke. 

Immunization or vaccine performed as a preventative measure to block the HPV vaccine component Virus Like Particle (VLP). The human immune system can recognize as HPV VLP. 

The vaccine is in the form of an injectable vaccine that is given about 0.5 cc and injected intra-muscular in the upper arm of patients. 

Vaccines to prevent potential viruses exposed to HPV types 16 and 18 are a major cause of cervical cancer prevention, the vaccine can suppress more than 70% of cases of cervical cancer caused by these two HPV types. 

HPV vaccine proven effective in preventing infection of oncogenic HPV 16 and 18. HPV vaccine aimed at women aged 10 to 55 years and given in three doses, ie, with periods of 0, 1 and 6 months, when one begins to vaccinate him, and then a month after the vaccine first and sixth month after the second vaccine. However, the cost for the HPV vaccine itself is still quite expensive.